Physicochemical characterization and in vivo evaluation of solid self-nanoemulsifying drug delivery system for oral administration of docetaxel

References

• Aapro M. The scientific rationale for developing taxoids. Antican Drugs 1996; 7: 33–6
   PubMedGoogle Scholar
• Balakrishnan P, Lee BJ, Oh DH, Kim JO, Hong MJ, Jee JP, Kim JA, Yoo BK, Woo JS, Yong CS, et al. Enhanced oral bioavailability of dexibuprofen by a novel solid self-nanoemulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm 2009a; 72: 539–45
   PubMed Web of Science ®Google Scholar
• Balakrishnan P, Lee BJ, Oh DH, Kim JO, Lee YI, Kim DD, Jee JP, Lee YB, Woo JS, Yong CS, et al. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm 2009b; 374: 66–72
   PubMed Web of Science ®Google Scholar
• Choi HG, Kim MH, Lee MK, Kim CK. Effect of additives on the physicochemical properties of liquid suppository. Int J Pharm 1999; 190: 13–19
   PubMed Web of Science ®Google Scholar
• Choi YK, Poudel BK, Marasini N, Yang KY, Kim JW, Kim JO, Choi HG, Yong CS. Enhanced solubility and oral bioavailability of itraconazole by combining membrane emulsification and spray drying technique. Int J Pharm 2012; 434: 264–71
   PubMed Web of Science ®Google Scholar
• Craig D, Barker S, Banning D, Booth S. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm 1995; 114: 103–10
   Web of Science ®Google Scholar
• Engels FK, Mathot RA, Verweij J. Alternative drug formulations of docetaxel: A review. Anticanc Drugs 2007; 18: 95–103
   PubMed Web of Science ®Google Scholar
• Gelderblom H, Loos WJ, Verweij J, van der Burg ME, de Jonge MJ, Brouwer E, Nooter K, Stoter G, Sparreboom A. Modulation of cisplatin pharmacodynamics by Cremophor EL; experimental and clinical studies. Eur J Cancer 2002; 38: 205–13
   PubMed Web of Science ®Google Scholar
• Gueritte-Voegelin F, Guenard D, Lavelle F, Legoff MT, Mangatal L, Poiter P. Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem 1991; 34: 992–8
   PubMedGoogle Scholar
• Kang JH, Oh DH, Oh YK, Yong CS, Choi HG. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS). Eur J Pharm Biopharm 2012; 80: 289–97
   PubMed Web of Science ®Google Scholar
• Kim DW, Kang JH, Oh DH, Yong CS, Choi HG. Development of novel flurbiprofen-loaded solid self-microemulsifying drug delivery system using gelatin as solid carrier. J Microencapsul 2012; 29: 323–30
   PubMed Web of Science ®Google Scholar
• Kintzel PE, Michaud LB, Lange MK. Docetaxel-associated epiphora. Pharmacotherapy 2006; 26: 853–67
   PubMed Web of Science ®Google Scholar
• Lavelle F, Bissery MC, Combeau C, Riou JF, Vrignaud P, André S. Preclinical evaluation of docetaxel (Taxotere). Semin Oncol 1995; 22: 3–16
   Web of Science ®Google Scholar
• Li DX, Oh YK, Lim SJ, Kim JO, Yang HJ, Sung JH, Yong CS, Choi HG. Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique. Int J Pharm 2008; 355: 277–84
   PubMed Web of Science ®Google Scholar
• McDonald SL, Stevenson DA, Moir SE, Hutcheon AW, Haites NE, Heys SD, Schofield AC. Genomic changes identified by comparative genomic hybridisation in docetaxel-resistant breast cancer cell lines. Eur J Cancer 2005; 41: 1086–94
   PubMedGoogle Scholar
• Mu CF, Balakrishnan P, Cui FD, Yin YM, Lee YB, Choi HG, Yong CS, Chung SJ, Shim CK, Kim DD. The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel. Biomaterials 2010; 31: 2371–9
   PubMed Web of Science ®Google Scholar
• Nazzal S, Khan M. Controlled release of a self-emulsifying formulation from a tablet dosage form: Stability assessment and optimization of some processing parameters. Int J Pharm 2006; 315: 110–21
   PubMed Web of Science ®Google Scholar
• Oh DH, Kang JH, Kim DW, Lee BJ, Kim JO, Yong CS, Choi HG. Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier. Int J Pharm 2011; 420: 412–18
   PubMed Web of Science ®Google Scholar
• Persohn E, Canta A, Schoepfer S, Traebert M, Mueller L, Gilardini A, Galbiati S, Nicolini G, Scuteri A, Lanzani F, et al. G. Morphological and morphometric analysis of paclitaxel and docetaxelinduced peripheral neuropathy in rats. Eur J Cancer 2005; 41: 1460–6
   PubMed Web of Science ®Google Scholar
• Pradhan R, Lee DW, Choi HG, Yong CS, Kim JO, Fabrication of a uniformly sized fenofibrate microemulsion by membrane emulsification. J. Microencapsul. 2012 (PMID: 22657749)
   Google Scholar
• Prasad YVR, Puthli SP, Eaimtrakarn S, Ishida M, Yoshikawa Y, Shibata N, Takada K. Enhanced intestinal absorption of vancomycin with labrasol and-[alpha]-tocopheryl PEG 1000 succinate in rats. Int J Pharm 2003; 250: 181–90
   PubMed Web of Science ®Google Scholar
• Rao SVR, Shao J. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I Formulation development. Int J Pharm 2008; 362: 2–9
   PubMed Web of Science ®Google Scholar
• Ringel I, Horwitz SB. Studies with RP56976 (taxotere): A semisynthetic analogue of taxol. J Natl Cancer Inst 1991; 83: 288–91
   PubMed Web of Science ®Google Scholar
• the SOTGuiding principles in, use of animals in toxicology [Online]. Available at: www.toxicology.org/AI/FA/guidingprinciples.pdf Accessed at December 2008
   Google Scholar
• Tang B, Cheng G, Gu JC, Xu CH. Development of solid self-emulsifying drug delivery systems: Preparation techniques and dosage forms. Drug Discov Today 2008; 13: 606–12
   PubMed Web of Science ®Google Scholar
• Wang L, Dong J, Chen J, Eastoe J, Li X. Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci 2009; 330: 443–8
   PubMed Web of Science ®Google Scholar
• Woo JS, Song YK, Hong JY, Lim SJ, Kim CK. Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers. Eur J Pharm Sci 2008; 33: 159–65
   PubMed Web of Science ®Google Scholar
• Yan YD, Kim DH, Sung JH, Yong CS, Choi HG. Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin. Int J Pharm 2010; 399: 116–20
   PubMed Web of Science ®Google Scholar
• Yi T, Wan J, Xu H, Yang X. A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur J Pharm Biopharm 2008; 70: 439–44
   PubMed Web of Science ®Google Scholar
• Yin YM, Cui FD, Mu CF, Choi MK, Kim JS, Chung SJ, Shim CK, Kim DD. Docetaxel microemulsion for enhanced oral bioavailability: Preparation and in vitro and in vivo evaluation. J Control Rel 2009; 140: 86–94
   PubMed Web of Science ®Google Scholar
• Yong CS, Oh YK, Kim YI, Kim JO, Yoo BK, Rhee JD, Lee KC, Kim DD, Park YJ, Kim CK, et al. Physicochemical characterization and in vivo evaluation of poloxamer-based solid suppository containing diclofenac sodium in rats. Int J Pharm 2005; 301: 54–61
   PubMed Web of Science ®Google Scholar